Cantor Fitzgerald
Cantor Fitzgerald is a leading brokerage service for Wall Street's fixed income inter-dealer community. Cantor is a recognized leader in the specialized areas of equity and fixed income capital markets, offering an impressive array of products and services to more than 5000 institutional clients around the world.
Cantor suffered a devastating loss on September 11, 2001, when the World Trade Center terrorist attacks claimed the lives of 658 of the company's 960 New York-based employees.
Howard W. Lutnick is the company's Chairman and CEO.
View Older Stories View More Recent Stories
-
ChaSerg Technology Acquisition Corp. Announces Closing of Underwriter’s Over-Allotment Option in Connection with its Initial Public Offering
-
ChaSerg Technology Acquisition Corp. Announces Closing of Underwriter’s Over-Allotment Option in Connection with its Initial Public Offering
-
Proteostasis Therapeutics (PTI) Prices 11M Share Common Offering at $6.75/Sh
-
Rambler Metals and Mining PLC: Q3 Production Results
-
Proteostasis Therapeutics Prices Public Offering of Common Stock
-
Krystal Biotech Announces Closing of Public Offering of Common Stock and Exercise in Full of Underwriters’ Over-Allotment Option
-
UPDATE: HealthStream (HSTM) PT Raised to $26 at Cantor Fitzgerald
-
PlacementTracker Publishes Q3 2018 Private Placement Market League Tables
-
Proteostasis Therapeutics (PTI) to Offer 9M Shares of Common Stock
-
Proteostasis Therapeutics Announces Proposed Public Offering of Common Stock
-
Tesaro (TSRO) PT Raised to $68 at Cantor Fitzgerald Following Strong SOLO1 Data
-
Regeneron (REGN) PT Jumps On Expectation For A Broad Asthma Label - Cantor Fitzgerald
-
Dynavax Technologies (DVAX) PT Raised to $32 at Cantor Fitzgerald
-
Cantor Fitzgerald Starts Ra Medical Systems Inc. (RMED) at Overweight
-
Endo International plc (ENDP) PT Raised to $18 at Cantor Fitzgerald After Speaking with Physicians
-
Krystal Biotech (KRYS) Prices 3M Share Offering at $20/Sh
-
Krystal Biotech Announces Pricing of $60.0 Million Public Offering of Common Stock
-
U.S. midterms a mere blip on equity options traders' radar
-
Luminex Corp. (LMNX) Reports Acquisition of MilliporeSigma's Flow Cytometry Portfolio for $75M
-
Luminex Corporation to Acquire MilliporeSigma's Flow Cytometry Portfolio
-
Orchid Island Capital Announces October 2018 Monthly Dividend and September 30, 2018 RMBS Portfolio Characteristics
-
Krystal Biotech (KRYS) Commences $60M Public Offering of Common Stoc
-
Krystal Biotech Announces Commencement of $60.0 Million Public Offering of Common Stock
-
UPDATE: Zoetis Inc. (ZTS) PT Raised to $105 at Cantor Fitzgerald
-
Eli Lilly (LLY) PT Raised to $128 at Cantor Fitzgerald
-
Pfizer (PFE) PT Raised to $53 at Cantor Fitzgerald
-
IBM (IBM) PT Lowered to $140 at Cantor Fitzgerald
-
UnitedHealth Group (UNH) PT Raised to $310 at Cantor Fitzgerald
-
Krystal Biotech (KRYS) PT Raised to $35 at Cantor Fitzgerald
-
Longevity Acquisition Corporation Announces Separate Trading of its Ordinary Shares, Rights and Warrants, Commencing October 15, 2018
-
Longevity Acquisition Corporation Announces Separate Trading of its Ordinary Shares, Rights and Warrants, Commencing October 15, 2018
-
Pre-Open Movers 10/12: (CORI) (TTPH) (SQ) Higher; (IMDZ) (TRVN) Lower (more...)
-
After-Hours Stock Movers 10/11: (CORI) (TTPH) (PGNX) Higher; (TRVN) (IMDZ) Lower (more...)
-
Pacific Biosciences of California (PACB) PT Raised to $8 at Cantor Fitzgerald
-
Cantor Fitzgerald Starts International Money Express (IMXI) at Overweight
-
Cantor Fitzgerald Starts Foamix Pharmaceuticals (FOMX) at Overweight
-
Kala Pharmaceuticals Announces Full Exercise of Underwriters’ Option to Purchase Additional Shares
-
Amedisys (AMED) PT Raised to $125 at Cantor Fitzgerald
-
SeaSpine Holdings (SPNE) Prices 3.25M Share Offering at $15.50/Share
-
SeaSpine Prices Public Offering of Common Stock
-
SeaSpine Holdings (SPNE) Commences Offering of Common Stock
-
SeaSpine Commences Public Offering of Common Stock
-
ChaSerg Technology Acquisition Corp. Announces Closing of $200,000,000 Initial Public Offering
-
ChaSerg Technology Acquisition Corp. Announces Closing of $200,000,000 Initial Public Offering
-
Cantor Fitzgerald Starts Nightstar Therapeutics (NITE) at Overweight
-
AcelRx (ACRX) Could Have Positive AdCom Vote - Cantor Fitzgerald
-
Freddie Mac Prices $1.1 Billion Multifamily K-Deal, K-081
-
ChaSerg Technology Acquisition Corp. (CTAC) Prices 20M Units IPO at $10/Unit
-
ChaSerg Technology Acquisition Corp. Announces Pricing of $200 Million Initial Public Offering
-
ChaSerg Technology Acquisition Corp. Announces Pricing of $200 Million Initial Public Offering

